Latest filing published 18 Jun 2025 for Intellia Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Georgia Keresty: trading record in brief
This profile gathers the share dealings of Georgia Keresty across 3 companies, led by Intellia Therapeutics, Inc., Aspen Technology Inc and ASPENTECH Corp. Over a trading history stretching from 17 April 2019 to 11 June 2025, the count stands at 13 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 18 June 2025: a share grant, in Intellia Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Georgia Keresty
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares0Common StockSEC:0000950170-25-087887:0
- 7,737 shares0Common StockSEC:0000950170-24-073702:0
- 4,425 shares0Common StockSEC:0001209191-23-037892:0
- 5,197 shares0Common StockSEC:0001209191-22-037602:0
- 3,465 sharesCommon StockSEC:0001127602-22-014973:0
- 826 shares0Common StockSEC:0001127602-22-014476:0
- 1,569 shares0Common StockSEC:0000899243-22-014838:0
- 866 shares0Common StockSEC:0001127602-21-024890:0
- 2,094 shares0Common StockSEC:0001209191-21-043381:0
9 of 9 declarations
